Cholesteatoma Workup

  • Author: Peter S Roland, MD; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Apr 12, 2012
 

Imaging Studies

  • CT scanning is the imaging modality of choice because CT scanning can detect subtle bony defects (see the image below). However, CT scanning cannot always distinguish between granulation tissue and a cholesteatoma. Even technically excellent fine-cut CT scans cannot reliably determine the full extent of disease. The surgeon cannot always predict what is needed in the operating room based on findings from the preoperative evaluation. Both the operating surgeon and the patient must understand this limitation of the preoperative assessment and be prepared for intraoperative surprises.[10, 11, 12] Middle ear cholesteatoma. CT scan of an erosive chMiddle ear cholesteatoma. CT scan of an erosive cholesteatoma. The posterior canal wall has been eroded away, and the external auditory canal has filled with cholesteatomatous debris. Surprisingly, the middle ear is relatively free of disease.
  • Gaurano (2004) has demonstrated that expansion of the mastoid antrum can be seen in 92% of middle ear cholesteatomas and, similarly, 92% had CT demonstrable erosion of the ossicles.
  • The subtle bony defects that can be detected using CT a scan include the following:[12]
    • Scutal erosion
    • Labyrinthine fistula
    • Defects in the tegmen
    • Details of ossicular involvement
    • Details of ossicular erosion or discontinuity
    • Anomalies or invasion of the fallopian canal
  • MRI is used when very specific problems are expected to involve surrounding soft tissues. These problems including the following:[12]
    • Dural involvement or invasion
    • Subdural or epidural abscess
    • Herniated brain into the mastoid cavity
    • Inflammation of the membranous labyrinth or facial nerve
    • Sigmoid sinus thrombosis
  • A number of articles have recently appeared in the literature suggesting that diffusion weighted MRI may be able to distinguish between recurrent or persistent middle ear cholesteatoma and scar tissue or granulation tissue. If future studies verify both a high sensitivity and specificity, replacing routine second look procedures with high quality diffusion weighted MRI images may be possible.[13, 14]
  • Some surgeons reserve preoperative imaging for only special cases and are quite comfortable performing surgery without it. These surgeons may request a preoperative CT scan in the following circumstances:
    • If the diagnosis is in doubt: The diagnosis may be in doubt in individuals with only small attic retractions observed during the physical examination. CT scanning may help distinguish between shallow retractions without soft tissue extension into the epitympanic space and an extensive soft tissue mass with bony erosion. CT scanning can be helpful in individuals who have already had tympanomastoid surgery. In this group of patients, a white mass behind the tympanic membrane, as shown below, could represent tympanosclerosis, cartilage, or a recurrent cholesteatoma. CT scan findings frequently help resolve such questions. Diffusion weighted MRI may also be helpful in such circumstances. Middle ear cholesteatoma. A congenital cholesteatoMiddle ear cholesteatoma. A congenital cholesteatoma. A white mass can be seen behind an intact drum.
    • If the patient is adamant about avoiding an operation: Poor surgical candidates or patients who wish to avoid an operation for other reasons can be better advised about the risks of nonsurgical management if a CT has been performed and findings are evaluated. The presence of extensive disease, labyrinthine fistula, encroachment on the fallopian canal, and involvement of the oval window niche increase the risk of expectant management.
    • Helping a patient or parents assess some of the risks of ossicular involvement is often useful: If ossicular involvement is apparent on preoperative CT scans, parents should be counseled that ossicular removal may be necessary and significant postoperative conductive hearing loss should be expected.
    • If the underlying anatomy is indeterminate and the extent of disease is unclear as the result of previous surgery
    • In patients with congenital anomalies (eg, atresia cases, individuals with craniofacial anomalies)
    • If complications are suspected.
    • If labyrinthine fistula or erosion of the fallopian canal is suspected: In this case, CT scanning remains the procedure of choice.
    • If intracranial invasion, dural inflammation, meningitis, abscess, or sigmoid sinus thrombosis is suspected, MRI is indicated.
  • Other surgeons believe any patient with a cholesteatoma who is scheduled for surgical intervention should have a preoperative CT scan. They believe that useful information is obtained in every circumstance and, consequently, that the expense and radiation exposure is always justified.
Next

Other Tests

Incisional biopsies are unnecessary because the diagnosis can be made based on physical examination and radiography findings.

Previous
Next

Diagnostic Procedures

Audiometry should be performed prior to surgery whenever possible. Occasionally, a serious complication may require urgent surgery, and, in such cases, audiometric testing can be foregone. Air conduction, bone conduction, speech reception threshold, and speech discrimination scores should all be determined within a few weeks of the proposed operative procedure. No other diagnostic tests are generally necessary.

Previous
Next

Histologic Findings

The histology findings from surgically removed cholesteatoma specimens demonstrate typical squamous epithelium. The histology is indistinguishable from that of sebaceous cysts or keratomas removed from any other portion of the body.

Previous
 
 
Contributor Information and Disclosures
Author

Peter S Roland, MD  Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development

Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Laryngological Rhinological and Otological Society, American Neurotology Society, American Otological Society, North American Skull Base Society, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Alcon Labs Honoraria Speaking and teaching; Advanced Bionics Honoraria Board membership; Cochlear Corp Honoraria Board membership; Med El Corp travel grants Consulting; Foresight Consulting fee Consulting

Specialty Editor Board

Jack A Shohet, MD  President, Shohet Ear Associates Medical Group, Inc; Associate Clinical Professor, Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, School of Medicine

Jack A Shohet, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, American Neurotology Society, American Tinnitus Association, and California Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Gerard J Gianoli, MD  Clinical Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine; Vice President, The Ear and Balance Institute; Chief Executive Officer, Ponchartrain Surgery Center

Gerard J Gianoli, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society

Disclosure: Vesticon, Inc. None Board membership

Christopher L Slack, MD  Private Practice in Otolaryngology and Facial Plastic Surgery, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders

Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Medvoy Ownership interest Management position; Cerescan Imaging Consulting; Headwatersmb Consulting fee Consulting; Venturequest Royalty Consulting

Additional Contributors

The author is grateful for the expert help of Pam Henderson in the preparation of this manuscript.

References
  1. Ottaviani F, Neglia CB, Berti E. Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth?. Acta Otolaryngol. 1999;119(4):462-7. [Medline].

  2. De la Cruz A, Fayad JN. Detection and management of childhood cholesteatoma. Pediatr Ann. Jun 1999;28(6):370-3. [Medline].

  3. Janet C, L CS, L JA, A GK, C PB. Congenital cholesteatoma and cochlear implantation: Implications for management. Cochlear Implants Int. Mar 2 2012;[Medline].

  4. Lim HW, Yoon TH, Kang WS. Congenital cholesteatoma: clinical features and growth patterns. Am J Otolaryngol. Feb 21 2012;[Medline].

  5. Stapleton AL, Egloff AM, Yellon RF. Congenital cholesteatoma: predictors for residual disease and hearing outcomes. Arch Otolaryngol Head Neck Surg. Mar 2012;138(3):280-5. [Medline].

  6. Kemppainen HO, Puhakka HJ, Laippala PJ, et al. Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol. 1999;119(5):568-72. [Medline].

  7. Golz A, Goldenberg D, Netzer A, et al. Cholesteatomas associated with ventilation tube insertion. Arch Otolaryngol Head Neck Surg. Jul 1999;125(7):754-7. [Medline].

  8. Drahy A, De Barros A, Lerosey Y, Choussy O, Dehesdin D, Marie JP. Acquired cholesteatoma in children: Strategies and medium-term results. Eur Ann Otorhinolaryngol Head Neck Dis. Apr 2 2012;[Medline].

  9. Thompson JW. Cholesteatomas. Pediatr Rev. Apr 1999;20(4):134-6. [Medline].

  10. Tierney PA, Pracy P, Blaney SP, Bowdler DA. An assessment of the value of the preoperative computed tomography scans prior to otoendoscopic 'second look' in intact canal wall mastoid surgery. Clin Otolaryngol Allied Sci. Aug 1999;24(4):274-6. [Medline].

  11. Gaurano JL, Joharjy IA. Middle ear cholesteatoma: characteristic CT findings in 64 patients. Ann Saudi Med. Nov-Dec 2004;24(6):442-7. [Medline].

  12. Joel Swartz, H. Harnsberger. Imaging of the Temporal Bone. 3 Sub edition. New York: George Thieme Verlag; Oct 1, 1997.

  13. Vercruysse JP, De Foer B, Pouillon M, et al. The value of diffusion-weighted MR imaging in the diagnosis of primary acquired and residual cholesteatoma: a surgical verified study of 100 patients. Eur Radiol. Mar 3 2006;[Medline].

  14. Dubrulle F, Souillard R, Chechin D, et al. Diffusion-weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma. Radiology. Feb 2006;238(2):604-10.

  15. Roland PS, Meyerhoff WL. Open-cavity tympanomastoidectomy. Otolaryngol Clin North Am. Jun 1999;32(3):525-46. [Medline].

  16. Graham MD, Delap TG, Goldsmith MM. Closed tympanomastoidectomy. Otolaryngol Clin North Am. Jun 1999;32(3):547-54. [Medline].

  17. Visvanathan V, Kubba H, Morrissey MS. Cholesteatoma surgery in children: 10-year retrospective review. J Laryngol Otol. Feb 6 2012;1-4. [Medline].

  18. Roth TN, Haeusler R. Inside-out technique cholesteatoma surgery: a retrospective long-term analysis of 604 operated ears between 1992 and 2006. Otol Neurotol. Jan 2009;30(1):59-63. [Medline].

  19. Sanna M, Facharzt AA, Russo A, Lauda L, Pasanisi E, Bacciu A. Modified Bondy's technique: refinements of the surgical technique and long-term results. Otol Neurotol. Jan 2009;30(1):64-9. [Medline].

  20. Busaba NY. Clinical presentation and management of labyrinthine fistula caused by chronic otitis media. Ann Otol Rhinol Laryngol. May 1999;108(5):435-9. [Medline].

Previous
Next
 
Middle ear cholesteatoma. Attic cholesteatoma. This is a typical primary acquired cholesteatoma in its earliest stages.
Middle ear cholesteatoma. A large cholesteatoma. No landmarks are visible, which typically is the case with advanced cholesteatomas.
Middle ear cholesteatoma. A congenital cholesteatoma. A white mass can be seen behind an intact drum.
Middle ear cholesteatoma. A large attic cholesteatoma that is much more advanced than the one in the image depicting primary acquired cholesteatoma in its earliest stages.
Middle ear cholesteatoma. CT scan of an erosive cholesteatoma. The posterior canal wall has been eroded away, and the external auditory canal has filled with cholesteatomatous debris. Surprisingly, the middle ear is relatively free of disease.
Middle ear cholesteatoma. A large, adequate meatoplasty. Such a meatoplasty is usually necessary to create a problem-free cavity.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.